Search

Albert Sattin

from Los Angeles, CA
Get Report
Also known as:
Albert Edu, A Sattin
Phone and address:
1811 Barry Ave, Los Angeles, CA 90025
(310) 477-6687
Connected to:
Erica R Sattin, 43Natasha S Sattin, 48Ruth Sattin, 80Todd M Sattison, 54Amanda L Sattler, 47Bernard A Sattler, 80Brenda L Sattler, 53Charlotte B Sattler, 83Elinor A Sattler, 40Ellen R Sattler, 72

Albert Sattin Phones & Addresses

  • 1811 Barry Ave, Los Angeles, CA 90025 (310) 477-6687 (310) 663-6687
  • Bronx, NY
  • Indianapolis, IN
  • Sepulveda, CA
  • Westminster, CA
  • 1811 Barry Ave, Los Angeles, CA 90025

Work

Company: Ucla Position: Professor

Education

School / High School: Case Western Reserve University School of Medicine 1957

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Psychiatry, 1979

Emails

a***[email protected]

Industries

Research

Specialities

Neuropsychiatry (Psychiatry)

Professional Records

Medicine Doctors

Albert Sattin Photo 1

Dr. Albert Sattin, Los Angeles CA - MD (Doctor of Medicine)

View page
Specialties:
Neuropsychiatry (Psychiatry)
Address:
11301 Wilshire Blvd, Los Angeles, CA 90073
(310) 268-4440 (Phone)
Certifications:
Psychiatry, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 1957
Medical School
Barnes-Jewish Hospital
Graduated: 1957
Medical School
University Hospitals Of Cleveland
Graduated: 1957
Medical School
Inst Psych
Graduated: 1957

Resumes

Resumes

Albert Sattin Photo 2

Professor

View page
Location:
Los Angeles, CA
Industry:
Research
Work:
Ucla
Professor

Publications

Us Patents

Tri-Peptides For Neurological And Neurobehavior Applications

View page
US Patent:
20020151502, Oct 17, 2002
Filed:
Nov 14, 2001
Appl. No.:
10/002878
Inventors:
Albert Sattin - Los Angeles CA, US
Albert Pekary - Culver City CA, US
Robert Lloyd - Duluth MN, US
International Classification:
A61K038/06
C07K005/08
US Classification:
514/018000, 530/331000
Abstract:
Provided are pharmaceutical preparations including a manufactured peptide having the formula pGlu-R-Pro, wherein Ris Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier, and methods of treatment of neurological and neurobehavioral disorders therewith.

Tri-Peptides For Neurological And Neurobehavioral Applications

View page
US Patent:
20050009753, Jan 13, 2005
Filed:
Aug 18, 2004
Appl. No.:
10/922476
Inventors:
Albert Sattin - Los Angeles CA, US
Albert Pekary - Culver City CA, US
Robert Lloyd - Duluth MN, US
International Classification:
A61K038/05
US Classification:
514018000, 530331000
Abstract:
Provided are methods of treatment of neurological and neurobehavioral disorders utilizing pharmaceutical preparations including a manufactured peptide having the formula pGlu-R-Pro, wherein Ris Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.

Tri-Peptides For Antidepressant Applications

View page
US Patent:
20050233973, Oct 20, 2005
Filed:
Sep 13, 2004
Appl. No.:
10/940202
Inventors:
Albert Sattin - Los Angeles CA, US
Albert Pekary - Culver City CA, US
Robert Lloyd - Duluth MN, US
International Classification:
A61K038/05
US Classification:
514018000
Abstract:
Provided are methods of treatment of neurological and neurobehavioral disorders, including antidepressants for use in treatment of depression and related disorders, utilizing pharmaceutical preparations including a manufactured peptide having the formula pGlu-R-Pro, wherein Ris Glu, Phe, Leu, Tyr, Lys or Val, and preferably Gly, Lys, Leu or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.

Use Of Pyroglutamyl-Glutamyl-Prolyl Amide (Eep) For Neurological And Neurobehavioral Disorders

View page
US Patent:
6475989, Nov 5, 2002
Filed:
Oct 9, 1998
Appl. No.:
09/169657
Inventors:
Albert Sattin - Los Angeles CA, 90025
Albert E. Pekary - Culver City CA, 90230
Robert L. Lloyd - Duluth MN, 55805
International Classification:
A61K 3806
US Classification:
514 18, 530331
Abstract:
A tri-peptide drug for treatment of neurological and neurobehavioral disorders of a mammal, such drug being derived from the following formula: pGlu-X-Pro-NH , wherein the internal amino acid (X) is a non-histadine amino acid. Methods of treatment of neurological disorders using the tri-peptide, including as an adjunct, synergist or stand-alone therapy, in oral, parenteral, intranasal, transcutaneous, or rectal forms.
Control profile
Albert Sattin from Los Angeles, CA Get Report